Dyne Therapeutics, Inc. (DYN) Balance Sheet
As of 2026-06-30 (10-Q), Dyne Therapeutics, Inc. (DYN) reported total assets of $994.0M, total liabilities of $291.9M and shareholders' equity of $702.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $676.1M. Long-term debt: $199.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DYNDyne Therapeutics, Inc.Follow DYN — free
—
Price chart with a free account
- Market cap
- 2.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.30 | 0.20 | 0.17 | 0.12 | 0.44 | 0.89 | 0.68 | |
| Short-term investments | 0.04 | 0.18 | 0.08 | 0.00 | 0.21 | 0.22 | 0.22 | |
| Current assets | 0.35 | 0.38 | 0.27 | 0.13 | 0.66 | 1.13 | 0.94 | |
| Total assets | 0.35 | 0.43 | 0.31 | 0.17 | 0.69 | 1.19 | 0.99 | |
| Current liabilities | 0.01 | 0.03 | 0.03 | 0.05 | 0.04 | 0.05 | 0.08 | |
| Long-term debt | — | — | — | — | 0.00 | 0.15 | 0.20 | |
| Total liabilities | 0.01 | 0.06 | 0.05 | 0.07 | 0.06 | 0.21 | 0.29 | |
| Shareholders' equity | 0.34 | 0.37 | 0.25 | 0.09 | 0.63 | 0.97 | 0.70 |
USD billions · SEC XBRL
Dyne Therapeutics, Inc. — questions
- How much cash does Dyne Therapeutics, Inc. have?
- $676.1M in cash and cash equivalents as of 2026-06-30.
- How much debt does Dyne Therapeutics, Inc. have?
- $199.3M of long-term debt as of 2026-06-30.
- What are Dyne Therapeutics, Inc.'s total assets?
- $994.0M as of 2026-06-30.
- What is Dyne Therapeutics, Inc.'s shareholders' equity?
- $702.2M as of 2026-06-30.
Every figure on this page comes from Dyne Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.